News | February 17, 2009

First South-East Asian Clinic Adopts RapidArc

February 17, 2009 - Doctors in Hong Kong have carried out the first treatments in south-east Asia using RapidArc radiotherapy technology from Varian Medical Systems, and treated a 74-year-old patient with localized prostate cancer.
Clinicians at the Pamela Youde Nethersole Eastern Hospital (PYNEH) in Hong Kong said the first treatment took two to three minutes to deliver, much faster than conventional IMRT (intensity modulated radiotherapy) treatments.
“IMRT treatments are time-consuming because tumors are targeted by a complex sequence of fixed radiation beams from multiple angles but the RapidArc treatment is dramatically faster," said Dr. T.K. Yau, consultant radiation oncologist. “The RapidArc treatment can produce comparable or even better dose conformity compared with IMRT treatments, but with shorter treatment times. It means that more of our patients can be treated with advanced IMRT-quality treatments.”
Dr. Yau said the hospital now plans to expand the range of RapidArc treatments to include other pelvic tumors and head and neck cancers. PYNEH is one of six public cancer centers in Hong Kong.
Doctors at PYNEH treat patients using three Varian linear accelerators including a Clinac 23Ex accelerator equipped with RapidArc radiotherapy technology, as acquired in 2008 thanks to a private donation. Dr. Yau says his department plans to equip a second accelerator with RapidArc in the coming months.

For more information: www.varian.com

Related Content

Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...
non-small cell lung cancer, NSCLC, IMRT, toxicity, intensity modulated radiation therapy, 3-D CRT, ASTRO 2015
News | Lung Cancer | October 28, 2015
October 28, 2015 — An analysis of an international, cooperative-led trial of patients with locally advanced non-small
pediatric ependymoma patients, immediate post-surgical radiation therapy, Children's Oncology Group ACNS0121 trial, ASTRO 2015
News | Radiation Therapy | October 22, 2015
Outcomes for pediatric patients as young as 12 months with ependymoma who are treated with immediate post-operative...
post-prostatectomy IG-IMRT, image-guided intensity-modulated radiation therapy, toxicity, ASTRO, Practical Radiation Oncology
Feature | Intensity Modulated Radiation Therapy (IMRT) | October 06, 2015
A prospective study of guideline-based postoperative image-guided intensity modulated radiation therapy (IG-IMRT) in...
IMRT, chemo-radiation, oropharyngeal, head and neck cancer, combination, quality of life, study, University of Michigan
News | Intensity Modulated Radiation Therapy (IMRT) | August 14, 2015
Combining intensity-modulated radiotherapy (IMRT) with chemotherapy to treat locally advanced oropharyngeal (head and...
Overlay Init